PrimeRx Pharmacy Management Software has made available a 13 page white paper diving into the current state of a COVID-19 vaccine and what your pharmacy can be doing to prepare to be an administration site.

In The White Paper You Will Read About:

The Road to a COVID-19 Vaccine
What will the Vaccine Look Like?
Building the Logistics Network
Vaccine “Equitable Allocation”
Pharmacists Approved for Vaccine Administration
Preparing your Pharmacy
PrimeRxTM – Your Partner in Safe COVID-19 Vaccine Administration and Compliance

From COVID-19 Vaccine White Paper introduction:

“As researchers race to produce a safe and effective COVID-19 vaccine, preparations are underway across multiple channels to ensure that once approved, the vaccine will be efficiently manufactured, distributed, and administered. Many professionals will have a role in this procedure, including the health care professionals who will actually administer the vaccine. This will include the nation’s pharmacists who in September, were authorized by the U.S. Department of Health and Human Services to administer COVID-19 vaccines approved by the Food and Drug Administration (FDA).

The 2019 NCPA Digest found 78 percent of pharmacies already serve as vaccine administrators, with most limiting their role to influenza immunizations. This means a majority of pharmacies already understand the protocols of vaccine administration, and the critical role of technology in automating and facilitating program management.

Authorizing pharmacists to help in this way was a logical decision by HHS, since pharmacists had previously been approved to administer COVID-19 tests. In addition pharmacists already play an important role in patient inoculations, administering an estimated 25 percent of total influenza vaccinations administered each year.

Request Your Copy of The White Paper Now

But given the urgent circumstances of the expected COVID-19 vaccine, including the accelerated pace at which it has been developed and the anticipated strong demand, pharmacists will find themselves on the front lines, a position to which they have grown accustomed during the long months of the pandemic.

Operation Warp Speed executive director Moncef Slaoui suggested the first Emergency Use Authorization (EUA) for a vaccine could be granted “around Thanksgiving,” in late November. Distribution of those dosages would be limited to first responders, and “at-risk” populations.

Pharmacists have undoubtedly received guidance about preparing for the vaccine from multiple respected sources including state pharmacy boards, federal agencies, and industry trade associations. The National Community Pharmacists Association (NCPA), for example, has been an excellent source of information, while the American Pharmacists Association (APhA) has been at the forefront of efforts to ensure pharmacists’ role in this critical and historic endeavor.

Download the white paper now for an overview of the vaccine development process, along with information about how pharmacies can prepare for their important role. As the discussion will make clear, technology solutions, including the PrimeRx™ pharmacy management system will be trusted partners throughout the COVID- 19 vaccination period.”